Prelude Capital Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
13,629
+2,061
+18% +$147K 0.08% 299
2025
Q4
$714K Buy
+11,568
New +$681K 0.05% 408
2025
Q3
Sell
-5,398
Closed -$315K 1308
2025
Q2
$315K Buy
+5,398
New +$305K 0.03% 597
2022
Q4
Sell
-8,104
Closed -$676K 1518
2022
Q3
$676K Buy
8,104
+1,095
+16% +$94.2K 0.02% 541
2022
Q2
$559K Buy
+7,009
New +$681K 0.02% 762
2021
Q4
Sell
-4,442
Closed -$288K 2168
2021
Q3
$288K Buy
+4,442
New +$272K 0.01% 1155
2020
Q4
Sell
-590
Closed -$23K 1765
2020
Q3
$23K Sell
590
-407
-41% -$14.8K ﹤0.01% 1306
2020
Q2
$32K Buy
997
+765
+330% +$26.6K ﹤0.01% 1276
2020
Q1
$8K Buy
+232
New +$9.29K ﹤0.01% 1166
2018
Q4
Sell
-2,282
Closed -$132K 2052
2018
Q3
$132K Buy
2,282
+322
+16% +$17.8K 0.01% 894
2018
Q2
$107K Sell
1,960
-4,953
-72% -$246K 0.01% 896
2018
Q1
$327K Buy
+6,913
New +$346K 0.02% 560

Other funds holding NTR

Prelude Capital Management's NTR Position: Q1 2026 in Review

Prelude Capital Management increased its Nutrien (NTR) stake by 18% in Q1 2026, buying an estimated $147K and bringing the position to 13,629 shares worth $1.03M. The position accounts for 0.08% of the portfolio, ranked #299.

Prelude Capital Management first reported a position in NTR in Q1 2018 and has held it in 12 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Prelude Capital Management held 13,629 shares of Nutrien worth $1.03M as of Q1 2026.
  • Prelude Capital Management bought 2,061 Nutrien shares in Q1 2026, an estimated $147K.
  • Nutrien made up 0.08% of Prelude Capital Management's portfolio in Q1 2026, its #299 holding.
  • Prelude Capital Management first reported a position in Nutrien in Q1 2018 and has held it in 12 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.